Retrospective comparative study demonstrates pronounced microcytosis and anemia in adults with hemoglobin D and thalassemia, highlighting the necessity of molecular testing for diagnosis.
To characterize the hematologic effects of hemoglobin D (HbD) alone and in the presence of co-inherited α- or β-thalassemia, and to quantify associations with anemia, microcytosis, and hypochromia relative to normal-CBC controls. This retrospective comparative study included 202 adults with molecularly confirmed HbD-Punjab, HbD only (n = 79), HbD plus β-thalassemia (n = 78), and HbD plus α-thalassemia (n = 45), and 100 normal-CBC controls. Hematologic indices were compared using Welch’s one-way ANOVA or the Kruskal–Wallis test, with appropriate post hoc analyses. Case-control analyses evaluated anemia (Hb <12 g/dL), microcytosis (MCV <80 fL), and hypochromia (MCH <26 pg). A post hoc analysis used sex-specific anemia thresholds. WBC, RBC, Hb, MCV, MCH, HCT, and MCHC differed across the four groups (all p ≤ 0.002), whereas HCT did not (p = 0.523). HbD plus β-thalassemia had the lowest MCV (65.67 ± 6.85 fL) and MCH (21.12 ± 2.55 pg), which were significantly lower than in the HbD-only and HbD plus α-thalassemia groups (all p < 0.01). Hemoglobin did not differ significantly among the three HbD subgroups. Compared with controls, anemia was associated with HbD only (OR = 8.3, 95% CI 3.22–25.74), HbD plus β-thalassemia (OR = 11.9, 95% CI 4.68–36.59), and HbD plus α-thalassemia (OR = 11.5, 95% CI 4.16–37.68). Microcytosis and hypochromia also differed significantly between HbD groups and controls (Fisher’s exact p < 0.001). Sex-specific sensitivity analyses preserved all associations with anemia. β-Thalassemia co-inheritance produced the most pronounced microcytic-hypochromic phenotype, whereas α-thalassemia had a less pronounced effect. HbD alone was associated with relatively mild changes in red-cell indices, but co-inherited thalassemia, particularly β-thalassemia, substantially altered the hematologic phenotype. Integrated hematologic, electrophoretic, and molecular assessment is important for accurate classification.
No takes yet. Share an insight, caveat, or question.
Mirzaei et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: